The invention describes a method and pharmaceutical compositions for
subcutaneous and intracutaneous injection for reduction of localized fat
deposits comprising the use of (3-sn-Phosphatidyl)-cholin as a main
active and supporting ingredient either on its own, diluted or in
combination with compounded agents to initiate the process of lipolysis
of the adipose tissue by activating the natural metabolism process in the
body. The method can be used on all excess adipose tissue of the body and
face, including medical conditions that result from metabolic disorders
or those originating from effects from pharmaceutical agents, in addition
or apart from lifestyle conditions or other known conditions that
generates the growth and expansion of fat cells to accumulate excess body
fat. It is the first known effective method of use of such agents in
subcutaneous and intracutaneous use that allows a cosmetic reduction of
adiposity without surgical intervention. The method of the invention has
made it possible to achieve satisfactory cosmetic results in one to four
treatment sessions.